Tolstrup AB - Search Results

1

Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes.

Rasmussen SK, Nielsen LS, Müller C, Bouquin T, Næsted H, Mønster NT, Nygaard F, Weilguny D, Frandsen TP, Tolstrup AB. Rasmussen SK, et al. Among authors: tolstrup ab. BMC Proc. 2011 Nov 22;5 Suppl 8(Suppl 8):O2. doi: 10.1186/1753-6561-5-S8-O2. eCollection 2011. BMC Proc. 2011. PMID: 22373259 Free PMC article. No abstract available.

2

Single-batch production of recombinant human polyclonal antibodies.

Nielsen LS, Baer A, Müller C, Gregersen K, Mønster NT, Rasmussen SK, Weilguny D, Tolstrup AB. Nielsen LS, et al. Among authors: tolstrup ab. Mol Biotechnol. 2010 Jul;45(3):257-66. doi: 10.1007/s12033-010-9270-9. Mol Biotechnol. 2010. PMID: 20306237 Free PMC article.

3

Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use.

Frandsen TP, Naested H, Rasmussen SK, Hauptig P, Wiberg FC, Rasmussen LK, Jensen AM, Persson P, Wikén M, Engström A, Jiang Y, Thorpe SJ, Förberg C, Tolstrup AB. Frandsen TP, et al. Among authors: tolstrup ab. Biotechnol Bioeng. 2011 Sep;108(9):2171-81. doi: 10.1002/bit.23166. Epub 2011 Apr 25. Biotechnol Bioeng. 2011. PMID: 21495017

4

Recombinant antibody mixtures: production strategies and cost considerations.

Rasmussen SK, Næsted H, Müller C, Tolstrup AB, Frandsen TP. Rasmussen SK, et al. Among authors: tolstrup ab. Arch Biochem Biophys. 2012 Oct 15;526(2):139-45. doi: 10.1016/j.abb.2012.07.001. Epub 2012 Jul 20. Arch Biochem Biophys. 2012. PMID: 22820097 Review.

5

Efficient expression from one CMV enhancer controlling two core promoters.

Andersen CR, Nielsen LS, Baer A, Tolstrup AB, Weilguny D. Andersen CR, et al. Among authors: tolstrup ab. Mol Biotechnol. 2011 Jun;48(2):128-37. doi: 10.1007/s12033-010-9353-7. Mol Biotechnol. 2011. PMID: 21113688

6

Manufacture of recombinant polyclonal antibodies.

Rasmussen SK, Rasmussen LK, Weilguny D, Tolstrup AB. Rasmussen SK, et al. Among authors: tolstrup ab. Biotechnol Lett. 2007 Jun;29(6):845-52. doi: 10.1007/s10529-007-9331-8. Epub 2007 Feb 20. Biotechnol Lett. 2007. PMID: 17310321 Review.

7

Production of target-specific recombinant human polyclonal antibodies in mammalian cells.

Wiberg FC, Rasmussen SK, Frandsen TP, Rasmussen LK, Tengbjerg K, Coljee VW, Sharon J, Yang CY, Bregenholt S, Nielsen LS, Haurum JS, Tolstrup AB. Wiberg FC, et al. Among authors: tolstrup ab. Biotechnol Bioeng. 2006 Jun 5;94(2):396-405. doi: 10.1002/bit.20865. Biotechnol Bioeng. 2006. PMID: 16596663

8

Development of recombinant human polyclonal antibodies for the treatment of complex human diseases.

Tolstrup AB, Frandsen TP, Bregenholt S. Tolstrup AB, et al. Expert Opin Biol Ther. 2006 Sep;6(9):905-12. doi: 10.1517/14712598.6.9.905. Expert Opin Biol Ther. 2006. PMID: 16918257 Review.

9

A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation.

Könitzer JD, Müller MM, Leparc G, Pauers M, Bechmann J, Schulz P, Schaub J, Enenkel B, Hildebrandt T, Hampel M, Tolstrup AB. Könitzer JD, et al. Among authors: tolstrup ab. Biotechnol J. 2015 Sep;10(9):1412-23. doi: 10.1002/biot.201400652. Epub 2015 Aug 26. Biotechnol J. 2015. PMID: 26212696

10

Overexpression of YY1 increases the protein production in mammalian cells.

Tastanova A, Schulz A, Folcher M, Tolstrup A, Puklowski A, Kaufmann H, Fussenegger M. Tastanova A, et al. J Biotechnol. 2016 Feb 10;219:72-85. doi: 10.1016/j.jbiotec.2015.12.005. Epub 2015 Dec 10. J Biotechnol. 2016. PMID: 26686315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters